Antibacterial Effects of Thymbra spicata L. Extracts on Escherichia coli O157:H7, Salmonella enterica subsp. enterica serovar Typhimurium, and Campylobacter jejuni

Year 2018, Volume: 2 Issue: 1, 21 - 24, 30.06.2018

Gamze Çinar Nurşen Yaman Muhsin Aydın

https://doi.org/10.31594/commagene.399819

Cited By: 1

Abstract

In this study, the antibacterial effects of extracts acquired from the leaves of zahter (Thymbra spicata L.) plant, a traditional thyme, were investigated on Escherichia coli O157:H7, Salmonella enterica subsp. enterica serovar Typhimurium, and Campylobacter jejuni that may cause various damages to human health. For this purpose, diffusion disc assays were performed. Each of the diffusion discs was impregnated with 10 µL of 3 different (10^-1, 10^-2, and 10^-3) dilutions that were diluted from the T. spicata extract homogenates. These discs were placed on the media that was previously cultured with E. coli O157:H7, S. enterica subsp. enterica serovar Typhimurium, and C. jejuni and growth behaviors of each bacteria were observed. According to the obtained results, both E. coli O157:H7 and S. enterica subsp. enterica serovar Typhimurium presented large inhibition zones to 10^-1 and 10^-2 dilutions (for E. coli O157:H7 21.3±1.7 and 17.7±1.3, respectively; and for S. enterica subsp. enterica serovar Typhimurium: 26.3±1.7 and 20.7±1.3, respectively) but low inhibition zones to 10^-3 dilution (8.3±2.1 and 10.0±0.8, respectively). It was observed that the C. jejuni strain formed zones all below 17 mm in all three different dilutions.

Keywords

T. spicata, antimicrobial, antibiotic, bacteria

Zahter (Thymbra spicata L.) Bitkisi Ekstraktının, Escherichia coli O157:H7, Salmonella enterica subsp. enterica serovar Typhimurium ve Campylobacter jejuni Üzerindeki Antibakteriyel Etkileri

Abstract

Bu çalışmada, zahter (Thymbra spicata L.) bitkisinin yapraklarından elde edilen ekstrakların insan sağlığına çok yönlü
zararlar verebilen Escherichia coli O157:H7, Salmonella enterica subsp. enterica serovar Typhimurium ve Campylobacter jejuni
bakterileri üzerindeki antibakteriyel etkileri araştırılmıştır. Bu amaç doğrultusunda, disk difüzyon yöntemi kullanılmıştır. Steril
disklerinin her birine T. spicata ekstraktının homojenatlardan yapılan 3 farklı (10^-1, 10^-2 ve 10^-3) dilüsyondan 10’ar µL emdirilmiş
ve bu diskler petri kapları içerisinde bulunan besiyerlerine ekimi yapılmış olan E. coli O157:H7, Salmonella enterica subsp.
enterica serovar Typhimurium ve C. jejuni bakterilerinin üreyeceği bölgelere bırakılarak üreme davranışları gözlemlenmiştir.
Çalışma sonuçlarına göre, yapılan ölçümlerde E. coli O157:H7’nin 10^-1 ve 10^-2’lik T. spicata ekstraktının bulunduğu etrafında
sırasıyla 21,3±1,7 ve 17,7±1,3 mm’lik zonlar oluşturduğu gözlemlenmiştir. Benzer şekilde, S. enterica subsp. enterica serovar
Typhimurium da 10^-1 ve 10^-2’lik T. spicata ekstraktı dilüsyonlarının etrafında sırasıyla 26,3±1,7 ve 20,7±1,3 mm’lik zonlar
oluşturmuştur. Fakat hem E. coli O157:H7 hem de Salmonella enterica subsp. enterica serovar Typhimurium 10^-3’lük dilüsyonda
dar inhibisyon zonları oluşturmuşlardır (sırasıyla 8,3±2,1 ve 10,0±0,8). C. jejuni türünün ise üç farklı dilüsyonun tamamında 17
mm’nin altında kalan zonlar oluşturduğu gözlemlenmiştir.

Keywords

T. spicata, antimikrobiyal, antibiyotik, bakteri

References

• Allen, H.K., Trachsel, J., Looft, T., & Casey, T.A. (2014). Finding alternatives to antibiotics. Annals of The New York Academy of Sciences, 1323(1), 91-100. http://dx.doi.org/10.1111/nyas.12468.
• Al-Mariri, A., & Safi, M. (2014). In vitro antibacterial activity of several plant extracts and oils against some gram-negative bacteria. Iranian Journal of Medical Sciences, 39(1), 36–43. PMCID: PMC3895893
• Baydar, H., Sağdiç, O., Özkan, G., & Karadoğan, T. (2004). Antibacterial activity and composition of essential oils from Origanum, Thymbra and Satureja species with commercial importance in Turkey. Food Control, 15, 169-172. http://dx.doi.org/10.1016/S0956-7135(03)00028- 8.
• Bhalodia, N. R., & Shukla, N. J. (2011). Antibacterial and antifungal activities from leaf extracts of Cassia fistula l.: An ethnomedicinal plant. Journal of Pharmaceutical Technology and Research, 2(2), 104–109. http://dx.doi.org/10.4103/2231-4040.82956.
• Coates, A. R. M., & Hu, Y. (2007). Novel approaches to developing new antibiotics for bacterial infections. British Journal of Pharmacology, 152(8), 1147–1154. http://dx.doi.org/10.1038/sj.bjp.0707432.
• Fair, R.J., & Tor, Y. (2014). Antibiotics and Bacterial Resistance in the 21st Century. Perspectives in Medicinal Chemistry, 6, 25–64. http://dx.doi.org/10.4137/PMC.S14459.
• Giannella, R. A. (1996). Salmonella. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; Chapter 21.
• Harbarth, S., & Samore, M. H. (2005). Antimicrobial resistance determinants and future control. Emerging Infectious Diseases, 11, 794- 801. http://dx.doi.org/10.3201/eid1106.050167.
• Haroun, M. F.,& Al-Kayali, R. S. (2016). Synergistic effect of Thymbraspicata L. extracts with antibiotics against multidrug- resistantStaphylococcus aureus and Klebsiella pneumoniae strains. Iranian Journal of Basic Medical Sciences, 19, 1193-1200. PMCID: PMC5126220.
• Luangtongkum, T., Jeon, B., Han, J., Plummer, P., Logue, C.M., & Zhang, Q. (2009). Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiology, 4(2), 189–200. http://dx.doi.org/10.2217/17460913.4.2.189.
• Öztekin, S., & Soysal, Y. (1998). Tıbbi ve aromatik bitkilerde ekstraksiyon yöntemleri. Tarımsal Mekanizasyon 18. Ulusal Kongresi, 17-18 Eylül, Tekirdağ, Türkiye.
• Reller, L.B., Weinstein, M., Jorgensen, J.H., & Ferraro, M.J. (2009). Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices. Clinical Infectious Diseases, 49(11), 1749– 1755. https://doi.org/10.1086/647952.
• Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M. A., Roy, S. L.,Jones, J. L., … Griffin, P.M. (2011). Foodborne illness acquired in the United States—Major pathogens. Emerging Infectious Diseases, 17(1), 7–15. http://dx.doi.org/10.3201/eid1701.P11101.
• Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013). The future of antibiotics and resistance. The New England Journal of Medicine, 368, 299–302.
• Torella, J. P., Chait, R., & Kishony, R. (2010). Optimal drug synergy in antimicrobial treatments. PLoS Computational Biology, 6, 1-8. https://doi.org/10.1371/journal.pcbi.1000796.
• Ventola, C.L. (2015). The Antibiotic Resistance Crisis. Pharmacy and Therapeutics, 40(4), 277–283. PMCID: PMC4378521.
• Wright, G.D., & Poinar H. (2012). Antibiotic Resistance is Ancient: Implications for Drug Discovery. Trends in Microbiology, 20(4), 157–159. http://dx.doi.org/10.1016/j.tim.2012.01.002.
• Wright, G.D. (2014). Something new: revisiting natural products in antibiotic drug discovery. Canadian Journal of Microbiology, 60(3), 147– 154. http://dx.doi.org/10.1139/cjm-2014-0063.
• http://www.bitkiler.gen.tr/zahter-bitkisi.html (Erişim Tarihi: 05.08.2016).